What is Viatris's R&D?

Viatris (VTRS) reported R&D of $248.6M in Q1 2026.

How has Viatris's R&D changed year-over-year?

Viatris's R&D increased by 12.0% year-over-year, from $222M to $248.6M.

What is the long-term trend for Viatris's R&D?

Over 4 years (2021 to 2025), Viatris's R&D has grown at a 6.5% compound annual growth rate (CAGR), from $751.1M to $965.9M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Viatris VTRS R&D

R&D at other companies

ANI PharmaceuticalsANIP

$10.6M+0.3%

AMP

Amphastar PharmaceuticalsAMPH

$26.74M+33.0%

Aquestive Therapeutics, Inc.AQST

$4.2M-21.6%

ARS Pharmaceuticals, Inc.SPRY

$4.34M+46.9%

Amneal Pharmaceuticals, Inc.AMRX

$38.38M-4.1%

Scilex Holding CompanySCLX

$3.21M+30.7%

Other financials

Income statement

See full

Revenue$3.5B+8.1%

Gross profit$1.2B-0.3%

Operating income-$79.7M+97.2%

Net income$176.4M+106%

EPS (diluted)$0.15+106%

Balance sheet

See full

Cash & equivalents$1.8B+139%

Total debt$14.6B+1.0%

Total equity$14.7B-6.3%

Total assets$36.8B-4.3%

Cash flow

See full

Operating cash flow$388.3M-27.5%

CapEx$39.9M-6.3%

Free cash flow$348.4M-29.3%

Valuation

See full

Market cap$19.09B+75.6%

Enterprise value$31.89B+27.2%

P/S1.3×+0.5×

Profitability

See full

Gross margin34.4%-2.5pp

Operating margin1%—

Net margin-2%-1.0pp

FCF margin12.3%-1.0pp

Returns & leverage

See full

Return on equity-2%-0.9pp

Debt / equity1×+0.1×

Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viatris's R&D?: Viatris (VTRS) reported R&D of $248.6M in Q1 2026.
How has Viatris's R&D changed year-over-year?: Viatris's R&D increased by 12.0% year-over-year, from $222M to $248.6M.
What is the long-term trend for Viatris's R&D?: Over 4 years (2021 to 2025), Viatris's R&D has grown at a 6.5% compound annual growth rate (CAGR), from $751.1M to $965.9M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.